BioPharma Dive - Latest News

Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t yet found a suitor and a pair of biotechs cut staff.

Feb 9, 2025 - 22:25
 0
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t yet found a suitor and a pair of biotechs cut staff.

Read More

Tags:

Previous Article

'Tough but necessary decisions': Frontier Medicines lays off staff to streamline...

Next Article

Immune drugmakers Alumis and Acelyrin to merge

Related Posts

Sanofi to take $250M charge on study failure for E. coli vaccine

Sanofi to take $250M charge on study failure for E. col...

Feb 13, 2025  0

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch

AstraZeneca’s next breast cancer drug; Madrigal’s accel...

Feb 26, 2025  0

Sanofi reaches consumer health deal; Supernus antidepressant fails study

Sanofi reaches consumer health deal; Supernus antidepre...

Feb 19, 2025  0